Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

77.96 USD -1.27 (-1.60%)
Official Closing Price Updated: 7:56 PM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,720,300
Open 78.91
Bid (Size) 77.95 (1)
Ask (Size) 78.53 (1)
Prev. Close 79.23
Today's Range 77.56 - 79.06
52wk Range 71.71 - 87.80
Shares Outstanding 2,530,315,668
Dividend Yield 3.34%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Better Therapeutics Appoints Dr. Risa Lavizzo-Mourey to its Board of Directors
Better Therapeutics, Inc., a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of... 
From Business Wire News Releases
3 Hot Biotech Penny Stocks To Watch In April 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed

Performance

YTD
-3.71%
-3.71%
1 Month
+2.22%
+2.22%
3 Month
-3.97%
-3.97%
6 Month
-1.58%
-1.58%
1 Year
-2.53%
-2.53%

More News

Read More
3 Penny Stocks To Watch As Biotech Jumps In April 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Merck Expands Safer Childbirth Cities Initiative to 20th Community-Led Project Advancing Maternal Health Equity During Black Maternal Health Week
Tags Corporate Social Responsibility NYSE:MRK merck for mothers
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alibaba Stock Is Spring-Loaded After an Unimpressive Start to 2021
Tags NYSE:BABA,OTCMKTS:ALBHF,NYSE:MRK,NASDAQ:PGJ,NYSEARCA:KWEB,NYSEARCA:GXC PGJ ALBHF
From InvestorPlace
Merck to Discontinue Development of MK-7110 for COVID-19
From Business Wire News Releases
Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19
From Business Wire News Releases
Noteworthy ETF Inflows: VT, ADBE, CSCO, MRK
Tags ETFs
From ETF Channel
High-momentum stocks have been losing steam and this could signal a market top
Tags MRK VTRS MTUM
From MarketWatch
BofA Says GlaxoSmithKline's Decision To Halt Feladilimab Studies Is Disappointing
Tags Analyst Ratings Trading Ideas GSK
From Benzinga
Market Briefing For Monday, April 19
Tags Stocks / Equities Market News Pharma/Biotech
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.